Skip to content
healthcare.dev

Mucus Relief Xpect

NDC 63654-342, Guaifensin, Dextromethorphan, tablet, from Selder, S.A. de C.V..

Product NDC
63654-342
Status
Listed
Labeler
Selder, S.A. de C.V.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63654-342 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN400 mg/1
  • DEXTROMETHORPHAN HYDROBROMIDE20 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]

Package NDCNDC-11Package
63654-342-20636540342202 BLISTER PACK in 1 CARTON (63654-342-20) / 10 TABLET in 1 BLISTER PACK
63654-342-30636540342303 BLISTER PACK in 1 CARTON (63654-342-30) / 10 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63654-342 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63654-342 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63654-342. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.